ArticleFrontiers in oncology2026
Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary non-Hodgkin lymphoma (NHL) arising in skeletal muscle is exceedingly rare. We present a case of low-grade B-cell NHL involving the sternocleidomastoid muscle. A 67-year-old male presented with an asymptomatic, slowly growing left neck mass. Imaging revealed a 17 mm × 11 mm intramuscular nodule, initially suggestive of a benign lesion. Excisional biopsy demonstrated lymphoid proliferation with muscle infiltration. Immunohistochemistry revealed CD20(+), PAX5(+), BCL2(+), and monoclonal IgH rearrangement, consistent with low-grade B-cell NHL, most likely extranodal marginal zone lymphoma (ENMZL), non-gastric/non-cutaneous type. Staging confirmed Lugano stage I disease. Given the indolent nature, the patient was managed with active surveillance. This case highlights an unusual intramuscular presentation of NHL, emphasizing the importance of histopathological and molecular evaluation for accurate diagnosis and tailored management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.